Abcam (United Kingdom)

Abcam (United Kingdom)

Abcam Limited is a producer, distributor and seller of protein research tools operating worldwide from 13 locations with 1,800 employees of which 400 work in Research and Development. Abcam was listed on the Nasdaq and the London Stock Exchange until it was acquired by Danaher Corporation in 2023. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Abcam (United Kingdom), United Kingdom, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

90%


Total
Publications

1.1K


Total Open
Publications

1K


Total
Citations

12K


Open Access
Percentage

90%


Total
Publications

1.1K


Total Open
Publications

1K


Total
Citations

12K

Wikipedia

Website

download

Breakdown

68% 18% 4% 10%

Publisher Open

68%

Both

18%

Other Platform Open

4%

Closed

10%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

23%OA Journal

OA Journal 23%

226

Hybrid 21%

204

No Guarantees 56%

538

Other Platform Open

Other Internet 42%

102

Institution 41%

101

Public 29%

70

Domain 22%

53

Preprint 7%

16

Other Platform Locations

Name

Platform Type

Publications

Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Other Internet
66
Semantic Scholar
Public
64
PubMed Central
Domain
53
Unknown Repository
Other Internet
49
Europe PMC
Domain
32
AECID Library - Americanae
Institution
27
University of Cambridge - Apollo
Institution
10
Universidad de la Rioja - Dialnet
Institution
10
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Institution
9
bioRxiv
Preprint
9
1 / 8

Data updated 13 May 2024

Share

Share

Share